Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 66(6): 959-962, 2018 03 05.
Article in English | MEDLINE | ID: mdl-29121235

ABSTRACT

We report the presentation and management of 17 cases of Exophiala dermatitidis and Rhodotorula mucilaginosa bloodstream infections caused by a compounded parenteral medication at an oncology clinic. Twelve patients were asymptomatic. All central venous catheters were removed and antifungal therapy, primarily voriconazole, was administered to patients. Three patients died.


Subject(s)
Disease Management , Disease Outbreaks , Drug Contamination , Fungemia/drug therapy , Phaeohyphomycosis/drug therapy , Aged , Ambulatory Care Facilities , Antifungal Agents/therapeutic use , Asymptomatic Infections , Exophiala/drug effects , Exophiala/isolation & purification , Female , Fungemia/mortality , Humans , Immunocompromised Host , Male , Middle Aged , Oncology Service, Hospital , Outpatients , Phaeohyphomycosis/mortality , Rhodotorula/drug effects , Rhodotorula/isolation & purification
2.
Epidemiol Infect ; 145(11): 2269-2279, 2017 08.
Article in English | MEDLINE | ID: mdl-28629484

ABSTRACT

Mycobacterium marinum, a bacterium found in freshwater and saltwater, can infect persons with direct exposure to fish or aquariums. During December 2013, the New York City Department of Health and Mental Hygiene learned of four suspected or confirmed M. marinum skin or soft tissue infections (SSTIs) among persons who purchased whole fish from Chinese markets. Ninety-eight case-patients with non-tuberculous mycobacteria (NTM) SSTIs were identified with onset June 2013-March 2014. Of these, 77 (79%) were female. The median age was 62 years (range 30-91). Whole genome sequencing of clinical isolates revealed two main clusters and marked genetic diversity. Environmental samples from distributors yielded NTM though not M. marinum. We compared 56 case-patients with 185 control subjects who shopped in Chinese markets, frequency-matched by age group and sex. Risk factors for infection included skin injury to the finger or hand (odds ratio [OR]: 15·5; 95% confidence interval [CI]: 6·9-37·3), hand injury while preparing fish or seafood (OR 8·3; 95% CI 3·8-19·1), and purchasing tilapia (OR 3·6; 95% CI 1·1-13·9) or whiting (OR 2·7; 95% CI 1·1-6·6). A definitive environmental outbreak source was not identified.


Subject(s)
Disease Outbreaks , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium marinum/isolation & purification , Skin Diseases, Bacterial/epidemiology , Soft Tissue Infections/epidemiology , Adult , Aged , Aged, 80 and over , Animals , Case-Control Studies , Female , Fishes , Humans , Incidence , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/microbiology , New York City/epidemiology , Skin Diseases, Bacterial/microbiology , Soft Tissue Infections/microbiology
3.
MMWR Suppl ; 53: 23-7, 2004 Sep 24.
Article in English | MEDLINE | ID: mdl-15714622

ABSTRACT

New York City's first syndromic surveillance systems were established in 1995 to detect outbreaks of waterborne illness. In 1998, daily monitoring of ambulance dispatch calls for influenza-like illness began. After the 2001 World Trade Center attacks, concern about biologic terrorism led to the development of surveillance systems to track chief complaints of patients reporting to emergency departments, over-the-counter and prescription pharmacy sales, and worker absenteeism. These systems have proved useful for detecting substantial citywide increases in common viral illnesses (e.g., influenza, norovirus, and rotavirus). However, the systems have not detected more contained outbreaks earlier than traditional surveillance. Future plans include monitoring school health and outpatient clinic visits, augmenting laboratory testing to confirm syndromic signals, and conducting evaluation studies to identify which of these systems will be continued for the long term.


Subject(s)
Population Surveillance/methods , Public Health Informatics/trends , Bioterrorism/prevention & control , Communicable Diseases, Emerging/prevention & control , Disease Outbreaks/prevention & control , Humans , New York City
4.
Pediatrics ; 108(1): 54-60, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11433054

ABSTRACT

OBJECTIVE: To describe epidemiologic features of intussusception and rotavirus diarrhea in New York, to examine the baseline incidence and trends over time, and to ascertain whether an excess of cases occurred in the 9 months of vaccination with the newly licensed rotavirus vaccine. METHODS: Hospital discharge data from 1989 through 1998 were reviewed for children (<1 year old) whose primary or secondary diagnosis was coded as intussusception or rotavirus diarrhea. Characteristics of patients admitted for intussusception and rotavirus diarrhea were compared, and trends over time were examined. For a subset of patients, medical records and vaccine histories for intussusception hospitalizations from October 1998 through June 1999 were analyzed. The number of intussusception cases attributable to rotavirus vaccine was calculated based on the penetration of the vaccine (21%) and a range of excess risks of intussusception among vaccinated children as estimated by the National Immunization Program (NIP). RESULTS: From 1989 through 1998, 1450 intussusception-associated hospitalizations were reported in children <1 year old (average annual incidence 5.4/10 000). Among these children, 47% were treated medically and 53% had surgery, with 9% needing surgical resection. The incidence of intussusception declined over time from 6.1 per 10 000 in 1989 to 3.9 per 10 000 in 1998. Intussusception hospitalizations occurred throughout the year, whereas rotavirus-associated hospitalizations peaked from February to April. Of 20 patients with intussusception whose hospitalization charts were reviewed, 5 had received rotavirus vaccine. All 5 were hospitalized after their first dose of vaccine, were admitted before 7 months of age, were white, and had private insurance. A total of 81 cases of intussusception occurred during the 9-month period of rotavirus vaccination, compared with 78 during the same period in the prevaccination year. The number of excess intussusception cases observed (n = 3) was lower than expected using the NIP estimate of excess risk (1.8) among rotavirus vaccinated children (n = 12) but not significantly different from the risks identified in the NIP cohort studies (1 in 12 000). CONCLUSION: Our data suggest that in New York the rate of intussusception has declined, and approximately 1 child in 2600 develops intussusception before 1 year of age. The different seasonality between intussusception and rotavirus-related hospitalizations suggests that if any causal association exists, it must be small. Unlike other studies, analysis of New York hospitalized discharge data failed to show an appreciable increase in the incidence of intussusception after introduction of the rotavirus vaccine.


Subject(s)
Diarrhea/epidemiology , Diarrhea/microbiology , Intussusception/epidemiology , Rotavirus Infections/epidemiology , Rotavirus Infections/prevention & control , Rotavirus Vaccines/administration & dosage , Diarrhea/prevention & control , Female , Hospitalization/statistics & numerical data , Humans , Incidence , Infant , Male , New York/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...